Endometrial polyp secondary to tamoxifen therapy

Fertility and Sterility

Volumn 80, Issue 1, 2003, Pages 216-217

  Ansbacher, Rudi ^a   Advincula, Arnold P ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

AGED; ARTICLE; BENIGN TUMOR; CANCER CHEMOTHERAPY; CARCINOMA; CASE REPORT; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; HYSTEROSCOPY; PARTIAL MASTECTOMY; POLYP; PRIORITY JOURNAL; TRANSVAGINAL ECHOGRAPHY;

EID: 0038045072     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(03)00578-8     Document Type: Article

References (4)

1. Cohen I., Rosen D.J., Shapira J.L., Cordoba M., Gilboa S., Altaras M.M., et al. Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer. Br J Obstet Gynecol. 100:1993;567-570.
2. Van Leeuwen F.F., Benraadt J., Coebergh J.W., Kiemeney L.A., Gimbrere C.H., Otter R., et al. Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet. 343:(2):1994;448-452.
3. Mourits M.J.E., DeVries E.G.E., Willemse P.H.B., Ten Hoor K.A., Hollema H., Van der Zee A.G.J. Tamoxifen treatment and gynecologic side effects A review . Obstet Gynecol. 97:2001;855-866.
4. Committee Opinion, The American College of Obstetricians and Gynecologists, Number 232, April, 2000.